Publication | Open Access

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Metastatic Soft-tissue SarcomaVersus Intensified DoxorubicinOncologyMalignant DiseasePathologyFirst-line TreatmentPharmacotherapyCancer TreatmentMedicineRadiation Oncology